Associated Papers
Rapid clinical deployment of UBA1 testing in patients with VEXAS syndrome.
Wadsworth PA et al.
American Journal of Clinical Pathology, 2025
40418703 (PubMed )
Supplement: aqaf051_suppl_supplementary_material.pdf
Targeting enhanced cell death represents a potential therapeutic strategy for VEXAS syndrome.
Adachi S et al.
Rheumatology Advances in Practice, 2024
Select a paper to view details